← Back to Search

Fatherhood Engagement Program for Substance Use Disorders

N/A

Recruiting

Led By Scott Wetzler, PhD

Research Sponsored by Montefiore Medical Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline

Awards & highlights

No Placebo-Only Group

Summary

This trial will help Bronx families at risk of substance misuse get enhanced services, incl. motivational enhancement, a fatherhood program, & case management.

Who is the study for?

This trial is for fathers, whether they live with their children or not, who have at least one child under 18. They must be part of a family where someone is at risk for substance use issues. Fathers whose children are all in foster care cannot participate.

What is being tested?

The study tests if extra support services can help fathers in families at risk of substance misuse. Some dads will get usual services; others will also get motivational talks, the HERO Dads program, rewards for positive behavior (Contingency Management), and Case Management.

What are the potential side effects?

Since this trial involves behavioral interventions rather than medications, traditional side effects like those seen with drugs are not expected. However, participants may experience emotional discomfort or stress due to the sensitive nature of the topics discussed.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Child well-being, as measured by: Child Behavior Checklist

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Enhanced Fatherhood Services through Regional Partnership Grant Round 7 (RPG7)Experimental Treatment4 Interventions

Randomly assigned to receive enhanced RPG7 services (motivational enhancement, fatherhood engagement services, contingency management, case management)

Group II: Services as UsualActive Control1 Intervention

Randomly assigned to receive services as usual

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Case Management

2012

Completed Phase 2

~3370

Contingency Management

2014